Julia G. Butchko, Chief Development & Technology Officer at Immunovant, Inc. (IMVT), sold 541 shares at $4.72 ($3K) on 2022-04-27, disclosed to the SEC on 2022-04-29.
Open-market sale of $3k IMVT by Chief Development & Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |